Valerie Fleming
Family · Joplin, MONPI 1952629610
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 267 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,629 and has fallen 98.8% since, to $20 in 2025.
Across 267 payments — averaging $13.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$407
- Boehringer Ingelheim$386
- AstraZeneca$358
- Takeda Pharmaceuticals U.S.A., Inc.$329
- Novo Nordisk$257
- Lilly USA, LLC$248
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,669100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 24 | $407 |
| Boehringer Ingelheim | 20 | $386 |
| AstraZeneca | 25 | $358 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $329 |
| Novo Nordisk | 21 | $257 |
| Lilly USA, LLC | 19 | $248 |
| Amgen | 18 | $245 |
| Merck | 15 | $207 |
| Kowa Pharmaceuticals America, Inc. | 27 | $198 |
| Pfizer | 14 | $171 |
| Bayer | 7 | $115 |
| Biohaven Pharmaceuticals, Inc. | 10 | $113 |
| GSK | 8 | $110 |
| Astellas Pharma US Inc | 5 | $93 |
| Teva Pharmaceuticals USA, Inc. | 6 | $70 |
| Dexcom, Inc. | 5 | $66 |
| Idorsia Pharmaceuticals US Inc | 4 | $60 |
| Sanofi-aventis U.S. LLC | 4 | $57 |
| AbbVie | 3 | $42 |
| Exact Sciences | 2 | $33 |
| Novartis | 2 | $28 |
| Amarin Pharma, Inc. | 2 | $27 |
| Currax Pharmaceuticals LLC | 2 | $23 |
| Medtronic | 1 | $13 |
| Eisai Inc. | 1 | $13 |
How this compares
$3,669 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 26 | $723 |
| Losartan Potassium | 13 | $172 |
| Amlodipine Besylate | 17 | $158 |
| Rosuvastatin Calcium | 39 | $115 |
| Metoprolol Succinate | 14 | $89 |
| Lisinopril | 15 | $86 |
Paid to pharmacies, not to this prescriber.
Other family in Joplin
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
- Jennifer GriggColumbia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.